QNRX — Quoin Pharmaceuticals Share News
0.000.00%
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $1.61 a share - Earnings Preview
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM
NASDAQ RESUMED AT 10:03 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
NASDAQ RESUMED AT 09:49 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
NASDAQ RESUMED AT 10:21 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:11 AM
Quoin Pharmaceuticals Ltd reports results for the quarter ended June 30 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $7.41 a share - Earnings Preview
Quoin Pharmaceuticals Ltd reports results for the quarter ended March 31 - Earnings Summary
Quoin Pharmaceuticals Ltd expected to post a loss of $6.07 a share - Earnings Preview
Quoin Pharmaceuticals Ltd expected to post a loss of $6.07 a share - Earnings Preview
ADS Ratio Changed To 1 ADS Representing 35 Ordinary Shares - SEC Filing
Brief: Quoin Pharmaceuticals Approves ADS Ratio Change To 120